Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on China Health Report.
The Compassionate Crossroad of Value-Based Care, MAiD and Multimodal Pain Therapy; Olumuyiwa Bamgbade, Salem Pain Clinic
EIN Presswire
·
July 12, 2025
Reaffirming the ethics of compassionate medicine, value-based care, MAiD, and multimodal pain management; Olumuyiwa Bamgbade, Salem Pain Clinic Canada SURREY, BC, CANADA, July 12, 2025 /EINPresswire.com/ -- As Canada expands access to Medical...
Protecting Doctors from Extortion, Coercion, and Harassment in Pain Clinic; Olumuyiwa Bamgbade, Salem Pain Clinic Canada
EIN Presswire
·
July 12, 2025
Safeguarding healthcare by protecting physicians from extortion, coercion, and harassment in pain clinic settings; Olumuyiwa Bamgbade, Salem Pain Clinic Canada SURREY, BC, CANADA, July 12, 2025 /EINPresswire.com/ -- Physicians who serve in...
Airway and Breathing Care Lessons During COVID-19 Towards Enhancing Value-Based Healthcare; Olumuyiwa Bamgbade
EIN Presswire
·
July 12, 2025
A Case for Safer Systems in Value-Based Healthcare Delivery From Airway and Breathing Care Lessons During COVID-19; Olumuyiwa Bamgbade, Salem Pain Clinic Canada SURREY, BC, CANADA, July 12, 2025 /EINPresswire.com/ -- Tracheal intubation and...
Advancing Health Workforce Development Through Open Science and UN SDG 3 Goals; Olumuyiwa Bamgbade, Salem Pain Clinic
EIN Presswire
·
July 12, 2025
Using open science and UN SDG 3 goals to lead evidence-based transformation of the health workforce; Olumuyiwa Bamgbade, Salem Pain Clinic Canada SURREY, BC, CANADA, July 12, 2025 /EINPresswire.com/ -- The call for equitable, sustainable, and...
KIF18A Targeting Therapies FDA EMA Approval Clinical Trials By Indication Company Country Drug Class Report
GlobeNewswire, Inc.
·
July 12, 2025
Delhi, July 12, 2025 (GLOBE NEWSWIRE) -- Global KIF18A Targeting Therapies Market Trends, Clinical Trials, Technology Platforms & Future Outlook 2025 Report Highlights & Findings: First KIF18A Targeting Therapy Commercial Availability Expected By...
Medical Ozone Therapy Market Exclusive Report In Detailed Analysis Through 2032 | Kastner-Praxisbedarf, Promolife, HÃ
EIN Presswire
·
July 11, 2025
Medical Ozone Therapy Market is estimated to valued USD 594.4 Mn in 2025 and expected reach USD 887.9 Mn by 2032, growing at CAGR of 5.9% from 2025 to 2032. BURLINGAME, CA, UNITED STATES, July 11, 2025 /EINPresswire.com/ -- Coherent Market...
Cancer Antibody Drug Conjugates Treatment Market Size Clinical Trials FDA Approved Report
GlobeNewswire, Inc.
·
July 11, 2025
Delhi, July 11, 2025 (GLOBE NEWSWIRE) -- Global Cancer Antibody Drug Conjugates Market Size, Drugs Approval, Price, Sales and Clinical Trials Insight 2030 Report Finding & Inclusions: Global Cancer Antibody Drug Conjugates Market: 2020 – 2030...
ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Hims & Hers Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – HIMS
GlobeNewswire, Inc.
·
July 11, 2025
NEW YORK, July 11, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Hims & Hers Health, Inc. (NYSE: HIMS) between April 29, 2025 and June 23, 2025, both dates inclusive (the...
Bispecific Antibody Drug Conjugates Clinical Trials FDA Approval Market Trends Report
GlobeNewswire, Inc.
·
July 11, 2025
Delhi, July 11, 2025 (GLOBE NEWSWIRE) -- Global Bispecific Antibody Drug Conjugates Clinical Trials, Regulatory Approvals and Future Market Opportunity Outlook 2029 Report: Report Answers Question On Why There Exist Need For Bispecific Antibody...
ELV DEADLINE TODAY: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Elevance Health, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important July 11 Deadline in Securities Class Action – ELV
GlobeNewswire, Inc.
·
July 11, 2025
NEW YORK, July 11, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Elevance Health, Inc. (NYSE: ELV) between April 18, 2024 and October 16, 2024, both dates inclusive (the...
Reimagining Sickle Cell Arthropathy Care Through Value-Based Care Delivery; Olumuyiwa Bamgbade, Salem Pain Clinic Canada
EIN Presswire
·
July 11, 2025
Value-based healthcare can enable timely and optimal sickle cell arthropathy surgical care; Olumuyiwa Bamgbade, Salem Pain Clinic Canada SURREY, BC, CANADA, July 11, 2025 /EINPresswire.com/ -- Sickle cell disease (SCD) is a chronic,...
Lidocaine Swallow Enables Value-Based Pain Relief in Chronic Esophageal Disorders; Olumuyiwa Bamgbade, Salem Pain Clinic
EIN Presswire
·
July 11, 2025
Lidocaine swallow provides innovative value-based care for chronic severe painful prolonged esophageal disorders; Olumuyiwa Bamgbade, Salem Pain Clinic Canada SURREY, BC, CANADA, July 11, 2025 /EINPresswire.com/ -- Chronic esophageal pain is a...
Global Forecast of the Healthcare Provider Network Management Market (2024–2033): Regional Outlook
EIN Presswire
·
July 11, 2025
Healthcare Provider Network Management Market set to rise from USD 4.74 Billion in 2025 to USD 13.47 Billion by 2033, CAGR 13.94%. PUNE, MAHARASHTRA, INDIA, July 11, 2025 /EINPresswire.com/ -- Global Healthcare Provider Network Management Market...
Reframing Chronic Pain, Suffering, Dignity, and MAiD; Olumuyiwa Bamgbade, Salem Pain Clinic Canada
EIN Presswire
·
July 11, 2025
Chronic pain patients are reframing chronic suffering, dignity, and Medical Assistance in Dying (MAiD); Olumuyiwa Bamgbade, Salem Pain Clinic Canada SURREY, BC, CANADA, July 11, 2025 /EINPresswire.com/ -- Access to Medical Assistance in Dying...
Advancing Health Workforce Development Through Research Mentorship and Evidence-Based Management; Olumuyiwa Bamgbade
EIN Presswire
·
July 11, 2025
Research Mentorship and Evidence-Based Management Promotes Healthcare Workforce Development and Sustainability; Olumuyiwa Bamgbade, Salem Pain Clinic Canada SURREY, BC, CANADA, July 11, 2025 /EINPresswire.com/ -- In this era of rapid healthcare...
HHS leaders visit Phlow Corp. campus to see pharmaceuticals made from start to finish
American Hospital Association
·
July 10, 2025
Senior leaders from the U.S. Department of Health and Human Services’ Administration for Strategic Preparedness and Response, along with White House representatives, visited pharmaceutical company Phlow Corp.’s new production system that...
ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Hims & Hers Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – HIMS
GlobeNewswire, Inc.
·
July 11, 2025
NEW YORK, July 10, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Hims & Hers Health, Inc. (NYSE: HIMS) between April 29, 2025 and June 23, 2025, both dates inclusive (the...
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Rocket Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – RCKT
GlobeNewswire, Inc.
·
July 10, 2025
NEW YORK, July 10, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) between February 27, 2025 and May 26, 2025, both dates inclusive...
Cannabinoid Agonist Clinical Trial Pipeline Appears Robust With 20+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight
GlobeNewswire, Inc.
·
July 10, 2025
New York, USA, July 10, 2025 (GLOBE NEWSWIRE) -- Cannabinoid Agonist Clinical Trial Pipeline Appears Robust With 20+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight The cannabinoid agonist market is gaining...
Ascentage Pharma Announces Its Novel Bcl-2 Inhibitor Lisaftoclax Approved by China NMPA, Ushering in a New Era for the Treatment of CLL/SLL
GlobeNewswire, Inc.
·
July 10, 2025
ROCKVILLE, Md. and SUZHOU, China, July 10, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global biopharmaceutical company dedicated to addressing unmet medical needs in cancers, announced that its proprietary novel Bcl-2...